MedTrace Logo

Single Maximal Exercise Session and the Metabolic Response of Physically Inactive Young Adults (EASY-Study)

NCT06680713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-11-08

No results posted yet for this study

Summary

The goal of this clinical trial is to learn how the metabolic parameters of physically inactive young adults respond to a progressive exercise testing. The main questions it aims to answer are:

Does a progressive exercise test induce metabolic adaptations that differ from a normal or physiologic status? Does the changes in circulating insulin might indicate metabolic dysfunctions in physically inactive young adults? Researchers will compare the metabolic status at baseline (rest) and the responses immediately after the finalization of a progressive exercise test until fatigue by collecting blood and urine samples before and after the exercise testing.

Participants will:

Undergo a progressive exercise test on a cycle ergometer where vital signs such as heart rate, blood pressure, rating of perceived effort, pulse and muscle oximetry will be recorded during the test.

Visit the laboratory once where all procedure will be conducted there. Stay in touch for the following week in case some exercise-related symptoms develops.

Conditions

  • Physical Deconditioning

Interventions

BEHAVIORAL

Exercise

Progressive exercise testing on a cyclo ergometer

Sponsors & Collaborators

  • Universidad Austral de Chile

    collaborator OTHER

  • Sergio Martinez-Huenchullan

    lead OTHER

Principal Investigators

  • Sergio F Martinez-Huenchullan, PhD · Universidad San Sebastián

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-18
Primary Completion
2024-07-17
Completion
2024-07-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06680713 on ClinicalTrials.gov